Johnson & Johnson news from FiercePharma
NewsJ&J pays up for Pfizer consumer unit error
In 2006, Johnson and Johnson acquired a plant in Lititz, PA when it bought Pfizer's consumer health care division. Now federal lawmakers contend that the plant violated paperwork regulations for Read more...
Justice probes biliary stent marketing
The U.S. Department of Justice has launched a probe of the bile-duct stent market, trying to determine whether companies such as Abbott Laboratories, Boston Scientific and Johnson & Johnson Read more...
Bid-happy analysts play matchup
Analysts just can't get their minds off which drugmakers might make a deal next. The most recent suspects are Bayer and Onyx, which are partnered on the Read more...
J&J nabs Topamax patent extension
SPOTLIGHT: J&J nabs Topamax patent extensionJohnson & Johnson's epilepsy med Topamax won't go off patent in September as scheduled because the FDA has extended market exclusivity for one year Read more...
Study links J&J epilepsy med to birth defects
Just a week after FDA experts narrowly rejected a new black-box warning on epilepsy drugs, new research shows that one of them, Johnson & Johnson's Topamax, may increase the risk of birth Read more...
Panel gives mixed blessing to J&J's Doribax
Johnson & Johnson's Doribax squeaked through an FDA advisory panel yesterday, winning its blessing as an effective treatment for hospital-acquired pneumonia on a 7-6 vote. And at least one Read more...
J&J's consumer sales drive earnings growth
Mixed news on Johnson & Johnson today, too: Reporting its second-quarter results this morning, J&J announced a healthy 8 percent hike in net income on strong sales of its consumer products. Read more...
Amgen, J&J settle sales-discount lawsuit
SPOTLIGHT: Amgen, J&J settle sales-discount lawsuitAmgen agreed to pay $200 million to settle an antitrust lawsuit by Johnson & Johnson's Ortho Biotech unit, putting to rest 2½ years Read more...
Genentech, J&J earnings expected to rise
It's a big couple weeks for earnings, and so a couple of newspapers are offering a rundown on which pharma companies will report when and what results we're likely to see. Naturally, we're passing Read more...
New Jersey loses 800 pharma jobs
Schering-Plough will cut a minimum of 500 jobs starting on August 11th in New Jersey as part of a Read more...
| Press ReleasesPRESS RELEASE: Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology DURHAM, N.C. -- Nov 16, 2007 - Argos Therapeutics announced today that it has granted Therakos, Inc., Read more... PRESS RELEASE: Johnson & Johnson Announces Changes To Accelerate Growth Johnson & Johnson Announces Changes To Accelerate Growth Three New Units to Focus on Convergence and New Opportunities New Brunswick, NJ (November 15, 2007) – Johnson & Johnson today Read more... PRESS RELEASE: Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis BOSTON, Nov. 7 -- Patients with active psoriatic Read more... PRESS RELEASE: Court Throws Out Claim in J&J Lawsuit Against American Red Cross Court Throws Out Claim in J&J Lawsuit Against American Red Cross WASHINGTON, Tuesday, November 06, 2007 — A federal judge late yesterday dismissed an important part of the lawsuit brought by Read more... PRESS RELEASE: Third Quarter 2007 Financial Results Third Quarter 2007 Financial Results Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of $15.0 Billion Increased 12.7%; EPS was $.88, Including Special Charges; Excluding Special Read more... |
Get more Johnson & Johnson coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets